• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由该基因突变导致的常染色体显性遗传II型骨硬化症:一例报告。

Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.

作者信息

Song Xiu-Li, Peng Li-Yuan, Wang Dao-Wen, Wang Hong

机构信息

Genetic Diagnostic Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

出版信息

World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.

DOI:10.12998/wjcc.v10.i20.6936
PMID:36051116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9297392/
Abstract

BACKGROUND

Osteopetrosis is a family of extremely rare diseases caused by failure of osteoclasts and impaired bone resorption. Among them, autosomal dominant osteopetrosis type II (ADO II), related to the chloride channel 7 () gene, is the most frequent form of osteopetrosis. In this study, we report a mutation of in a patient without the family history of ADO II.

CASE SUMMARY

A 5-year-old Chinese boy with ADO II was found to have a mutation in the gene [c.746C>T (p.P249L)]. Typical clinical manifestations, including thickening of the cortex of spinal bones and long bones, non-traumatic fracture of the femoral neck, and femoral head necrosis, were found in this patient. The patient is the first reported case of ADO II with the missense mutation c.746C>T (p.P249L) of the gene reported in China. We also review the available literature on ADO II-related mutations, including baseline patient clinical features, special clinical significance, and common mutations.

CONCLUSION

Our report will enrich the understanding of mutations in ADO II patients. The possibility of a mutation should be considered in individuals who have no family history of osteopetrosis.

摘要

背景

骨质石化症是一类极为罕见的疾病,由破骨细胞功能障碍和骨吸收受损引起。其中,与氯离子通道7(CLCN7)基因相关的常染色体显性II型骨质石化症(ADO II)是骨质石化症最常见的形式。在本研究中,我们报告了1例无ADO II家族史患者的CLCN7基因突变情况。

病例摘要

一名5岁患ADO II的中国男孩被发现CLCN7基因存在[c.746C>T(p.P249L)]突变。该患者具有典型的临床表现,包括脊椎骨和长骨皮质增厚、非创伤性股骨颈骨折以及股骨头坏死。该患者是中国首例报道的携带CLCN7基因错义突变c.746C>T(p.P249L)的ADO II病例。我们还回顾了关于ADO II相关CLCN7基因突变的现有文献,包括患者的基线临床特征、特殊临床意义和常见突变。

结论

我们的报告将丰富对ADO II患者基因突变的认识。对于无骨质石化症家族史的个体,应考虑CLCN7基因突变的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a77/9297392/ab167a058d3d/WJCC-10-6936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a77/9297392/ab167a058d3d/WJCC-10-6936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a77/9297392/ab167a058d3d/WJCC-10-6936-g001.jpg

相似文献

1
Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.由该基因突变导致的常染色体显性遗传II型骨硬化症:一例报告。
World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.
2
Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients.CLCN7基因的新型突变在中国患者中导致常染色体显性II型骨硬化症(ADO-II)和中间型常染色体隐性骨硬化症(IARO)。
Osteoporos Int. 2016 Mar;27(3):1047-1055. doi: 10.1007/s00198-015-3320-x. Epub 2015 Sep 22.
3
Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II).两个常染色体显性遗传性骨硬化症(II型)中国家系中CLCN7基因突变的鉴定。
J Bone Miner Metab. 2009;27(4):444-51. doi: 10.1007/s00774-009-0051-0. Epub 2009 Mar 14.
4
Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.一名患有II型常染色体显性骨硬化症老年女性患者的基因分析
Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.
5
Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).中国常染色体显性遗传性骨硬化症(II型)家系中CLCN7基因的两个新突变
J Bone Miner Metab. 2016 Jul;34(4):440-6. doi: 10.1007/s00774-015-0682-2. Epub 2015 Jun 9.
6
Clinical and genetic diagnosis of autosomal dominant osteopetrosis type II in a Chinese family: A case report.一个中国家庭中II型常染色体显性骨硬化症的临床与基因诊断:病例报告
World J Clin Cases. 2023 Jan 26;11(3):700-708. doi: 10.12998/wjcc.v11.i3.700.
7
Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.常染色体显性遗传性骨硬化症:94例氯离子通道7基因突变患者的临床严重程度及自然病史。
J Clin Endocrinol Metab. 2007 Mar;92(3):771-8. doi: 10.1210/jc.2006-1986. Epub 2006 Dec 12.
8
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.阿尔伯斯-尚伯格病(常染色体显性遗传性骨硬化症II型)由ClCN7氯通道基因突变引起。
Hum Mol Genet. 2001 Dec 1;10(25):2861-7. doi: 10.1093/hmg/10.25.2861.
9
Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene.常染色体显性骨硬化症(ADO)由 TCIRG1 基因中的错义变异引起。
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1726-1732. doi: 10.1210/clinem/dgae040.
10
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.氯离子通道ClCN7突变是导致严重隐性、显性和中间型骨硬化症的原因。
J Bone Miner Res. 2003 Oct;18(10):1740-7. doi: 10.1359/jbmr.2003.18.10.1740.

引用本文的文献

1
A novel frameshift variant leads to familial osteopetrosis with variable phenotypes in a Chinese Han consanguineous family.一种新的移码变异导致一个中国汉族近亲家庭出现具有可变表型的家族性骨质石化症。
BMC Med Genomics. 2025 Feb 24;18(1):36. doi: 10.1186/s12920-025-02101-y.

本文引用的文献

1
A Novel Variant in Regulates the Coupling of Angiogenesis and Osteogenesis.中的一种新型变体调节血管生成与骨生成的耦合。
Front Cell Dev Biol. 2020 Nov 16;8:599826. doi: 10.3389/fcell.2020.599826. eCollection 2020.
2
Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification.由于新产生的 CLCN7 变异对溶酶体酸化的影响导致溶酶体贮积和白化病。
Am J Hum Genet. 2019 Jun 6;104(6):1127-1138. doi: 10.1016/j.ajhg.2019.04.008. Epub 2019 May 30.
3
Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosis.
新型 CLCN7 突变导致常染色体显性骨硬化症 II 型和中间型常染色体隐性骨硬化症。
Mol Med Rep. 2019 Jun;19(6):5030-5038. doi: 10.3892/mmr.2019.10123. Epub 2019 Apr 3.
4
A Case of Autosomal Dominant Osteopetrosis Type 2 with a Gene Mutation.一例伴有基因突变的常染色体显性2型骨硬化症病例。
J Clin Res Pediatr Endocrinol. 2019 Nov 22;11(4):439-443. doi: 10.4274/jcrpe.galenos.2019.2018.0229. Epub 2019 Feb 14.
5
Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.一名患有II型常染色体显性骨硬化症老年女性患者的基因分析
Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.
6
Genetic Testing in Clinical Settings.临床环境中的基因检测。
Am J Kidney Dis. 2018 Oct;72(4):569-581. doi: 10.1053/j.ajkd.2018.02.351. Epub 2018 Apr 11.
7
Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADOII) and intermediate autosomal recessive osteopetrosis (ARO) in seven Chinese families.CLCN7基因的新型突变在七个中国家庭中导致了常染色体显性II型骨硬化症(ADOII)和中间型常染色体隐性骨硬化症(ARO)。
Postgrad Med. 2017 Nov;129(8):934-942. doi: 10.1080/00325481.2017.1386529. Epub 2017 Oct 11.
8
Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group.成骨不全症的诊断与管理:成骨不全症工作组的共识指南。
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-3123. doi: 10.1210/jc.2017-01127.
9
Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in .一名患有常染色体显性II型骨硬化症且携带.c.1856C>T突变的病例中破骨细胞生成增强但功能减退
Bone Res. 2016 Nov 29;4:16035. doi: 10.1038/boneres.2016.35. eCollection 2016.
10
Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.与肾小管酸中毒相关的常染色体显性遗传性骨硬化症是由CLCN7基因突变引起的。
Am J Med Genet A. 2016 Nov;170(11):2988-2992. doi: 10.1002/ajmg.a.37755. Epub 2016 Aug 19.